228 related articles for article (PubMed ID: 7748321)
1. Flumazenil in alcohol withdrawal.
Nutt D; Glue P; Wilson S; Groves S; Coupland N; Bailey J
Alcohol Alcohol Suppl; 1993; 2():337-41. PubMed ID: 7748321
[TBL] [Abstract][Full Text] [Related]
2. Flumazenil in alcohol withdrawal: a double-blind placebo-controlled study.
Potokar J; Coupland N; Glue P; Groves S; Malizia A; Bailey J; Wilson S; Nutt D
Alcohol Alcohol; 1997; 32(5):605-11. PubMed ID: 9373703
[TBL] [Abstract][Full Text] [Related]
3. Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study.
Gerra G; Zaimovic A; Giusti F; Moi G; Brewer C
Addict Biol; 2002 Oct; 7(4):385-95. PubMed ID: 14578014
[TBL] [Abstract][Full Text] [Related]
4. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
Reoux JP; Saxon AJ; Malte CA; Baer JS; Sloan KL
Alcohol Clin Exp Res; 2001 Sep; 25(9):1324-9. PubMed ID: 11584152
[TBL] [Abstract][Full Text] [Related]
5. Intravenous flumazenil following prolonged exposure to lormetazepam in humans: lack of precipitated withdrawal.
Gerra G; Giucasto G; Zaimovic A; Fertonani G; Chittolini B; Avanzini P; Caccavari R; Delsignore R
Int Clin Psychopharmacol; 1996 Jun; 11(2):81-8. PubMed ID: 8803645
[TBL] [Abstract][Full Text] [Related]
6. Reduction of aggression during benzodiazepine withdrawal: effects of flumazenil.
Saxon L; Borg S; Hiltunen AJ
Pharmacol Biochem Behav; 2010 Aug; 96(2):148-51. PubMed ID: 20451546
[TBL] [Abstract][Full Text] [Related]
7. Effects of flumazenil on ethanol withdrawal syndrome in rats.
Uzbay IT; Akarsu ES; Kayaalp SO
Arzneimittelforschung; 1995 Feb; 45(2):120-4. PubMed ID: 7710430
[TBL] [Abstract][Full Text] [Related]
8. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial.
Pomier-Layrargues G; Giguère JF; Lavoie J; Perney P; Gagnon S; D'Amour M; Wells J; Butterworth RF
Hepatology; 1994 Jan; 19(1):32-7. PubMed ID: 8276366
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of flumazenil for reversal of iatrogenic benzodiazepine-associated delirium toxicity during treatment of alcohol withdrawal, a retrospective review at one center.
Moore PW; Donovan JW; Burkhart KK; Waskin JA; Hieger MA; Adkins AR; Wert Y; Haggerty DA; Rasimas JJ
J Med Toxicol; 2014 Jun; 10(2):126-32. PubMed ID: 24619543
[TBL] [Abstract][Full Text] [Related]
10. The use of flumazenil in the anxious and benzodiazepine-dependent ECT patient.
Krystal AD; Watts BV; Weiner RD; Moore S; Steffens DC; Lindahl V
J ECT; 1998 Mar; 14(1):5-14. PubMed ID: 9661088
[TBL] [Abstract][Full Text] [Related]
11. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M
Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990
[TBL] [Abstract][Full Text] [Related]
12. Effects of nitrendipine, chlordiazepoxide, flumazenil and baclofen on the increased anxiety resulting from alcohol withdrawal.
File SE; Zharkovsky A; Hitchcott PK
Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jan; 16(1):87-93. PubMed ID: 1557510
[TBL] [Abstract][Full Text] [Related]
13. The anxiolytic etifoxine protects against convulsant and anxiogenic aspects of the alcohol withdrawal syndrome in mice.
Verleye M; Heulard I; Gillardin JM
Alcohol; 2009 May; 43(3):197-206. PubMed ID: 19393860
[TBL] [Abstract][Full Text] [Related]
14. Withdrawal and psychological sequelae, and patient satisfaction associated with subcutaneous flumazenil infusion for the management of benzodiazepine withdrawal: a case series.
Hulse G; O'Neil G; Morris N; Bennett K; Norman A; Hood S
J Psychopharmacol; 2013 Feb; 27(2):222-7. PubMed ID: 22596209
[TBL] [Abstract][Full Text] [Related]
15. Intravenous flumazenil following acute and repeated exposure to lorazepam in healthy volunteers: antagonism and precipitated withdrawal.
Griffiths RR; Evans SM; Guarino JJ; Roache JD; Furman WR; Liebson I; Schwam EM
J Pharmacol Exp Ther; 1993 Jun; 265(3):1163-74. PubMed ID: 8510001
[TBL] [Abstract][Full Text] [Related]
16. Oxcarbazepine--efficacy and tolerability during treatment of alcohol withdrawal: a double-blind, randomized, placebo-controlled multicenter pilot study.
Koethe D; Juelicher A; Nolden BM; Braunwarth WD; Klosterkötter J; Niklewski G; Wodarz N; Klatt J; Burtscheidt W; Gaebel W; Markus Leweke F
Alcohol Clin Exp Res; 2007 Jul; 31(7):1188-94. PubMed ID: 17511748
[TBL] [Abstract][Full Text] [Related]
17. A controlled study of flumazenil-precipitated withdrawal in chronic low-dose benzodiazepine users.
Mintzer MZ; Stoller KB; Griffiths RR
Psychopharmacology (Berl); 1999 Nov; 147(2):200-9. PubMed ID: 10591888
[TBL] [Abstract][Full Text] [Related]
18. Tolerance to the antinociceptive effects of ethanol during ethanol withdrawal.
Gatch MB
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):946-52. PubMed ID: 16574295
[TBL] [Abstract][Full Text] [Related]
19. Modulation of ethanol withdrawal-induced anxiety-like behavior during later withdrawals by treatment of early withdrawals with benzodiazepine/gamma-aminobutyric acid ligands.
Knapp DJ; Overstreet DH; Breese GR
Alcohol Clin Exp Res; 2005 Apr; 29(4):553-63. PubMed ID: 15834220
[TBL] [Abstract][Full Text] [Related]
20. Effects of benzodiazepines on acute and chronic ethanol-induced nociception in rats.
Gatch MB
Alcohol Clin Exp Res; 1999 Nov; 23(11):1736-43. PubMed ID: 10591589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
